Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 39 matching records.
39 results — page 1 of 2
- Level DAnimal StudyPubMed
Effects of Repeated Intravenous Injections of Autologous Adipose-Derived Mesenchymal Stromal Cells Expressing an Allogeneic MHC Protein in a Mouse Model of Diabetic Nephropathy.
Animal Study on Chronic Kidney Disease, Chronic Inflammation, Immune Modulation, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells1 citations - Level BClinical TrialEurope PMC
Allogeneic umbilical cord-derived mesenchymal stromal cells for treatment of refractory lupus nephritis: a real-world study
Clinical Trial on Chronic Kidney Disease, Autoimmune Research, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level BRandomized Controlled TrialPubMed
Intra-articular allogeneic adipose-derived mesenchymal stromal cell injections for stage III knee osteoarthritis: a double-blind placebo-controlled trial with 60-month follow-up.
Randomized Controlled Trial with a reported sample of 29 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
- n = 29
Stem Cells Transl Med - Level DLaboratory StudyPubMed
Potential Treatment of Steroid-Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report.
Laboratory Study on Hair Loss, Chronic Inflammation, Autoimmune Research, published in Clin Case Rep (2026) — summary generated from the PubMed abstract.
- 2026
Clin Case Rep - Level BRandomized Controlled TrialPubMed
Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation.
Randomized Controlled Trial with a reported sample of 31 on Immune Modulation, published in JHLT Open (2025) — summary generated from the PubMed abstract.
- 2025
- n = 31
JHLT Open2 citations - Level ARandomized Controlled TrialPubMed
Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients.
Randomized Controlled Trial with a reported sample of 214 on Cardiovascular Disease, published in Regen Med (2025) — summary generated from the PubMed abstract.
- 2025
- n = 214
Regen Med - Level BClinical TrialPubMed
Allogeneic mesenchymal stromal cell injections for knee osteoarthritis: a review of clinical outcomes.
Clinical Trial with a reported sample of 11 on Knee Osteoarthritis, Osteoarthritis, published in Regen Med (2025) — summary generated from the PubMed abstract.
- 2025
- n = 11
Regen Med - Level CCase Report / SeriesPubMed
Allogeneic mesenchymal stromal cell therapy for nonregenerative anemia in a FeLV-infected cat: a case report.
Case Report / Series on Systemic / IV, published in Cytotherapy (2025) — summary generated from the PubMed abstract.
- 2025
Cytotherapy - Level CProspective StudyPubMed
Long-Term Outcome Following Treatment With Allogeneic Mesenchymal Stem/Stromal Cells for Radiation-Induced Hyposalivation and Xerostomia.
Prospective Study with a reported sample of 10, published in Stem Cells Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 10
Stem Cells Transl Med8 citations - Level BClinical TrialPubMed
Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bone
Clinical Trial with a reported sample of 14, published in J Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 14
J Transl Med10 citations - Level CProspective StudyPubMed
Acceptability of Allogeneic Mesenchymal Stromal Cell-Based Tissue Engineering for the Treatment of Periodontitis: A Qualitative Study in France.
Prospective Study with a reported sample of 4, published in Int Dent J (2024) — summary generated from the PubMed abstract.
- 2024
- n = 4
Int Dent J - Level BRandomized Controlled TrialPubMed
Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.
Randomized Controlled Trial on Cardiovascular Disease, Stroke Research, published in Eur J Heart Fail (2023) — summary generated from the PubMed abstract.
- 2023
Eur J Heart Fail - Level CProspective StudyPubMed
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Prospective Study with a reported sample of 46 on Immune Modulation, published in Ann Hematol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 46
Ann Hematol - Level BClinical TrialPubMed
Cartilage regeneration and inflammation modulation in knee osteoarthritis following injection of allogeneic adipose-derived mesenchymal stromal cells: a phase II, triple-blinded, placebo controlled, randomized trial.
Clinical Trial with a reported sample of 40 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Immune Modulation, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
- n = 40
Stem Cell Res Ther70 citations - Level BClinical TrialPubMed
Subcutaneous Injection of Allogeneic Adipose-Derived Mesenchymal Stromal Cells in Psoriasis Plaques: Clinical Trial Phase I.
Clinical Trial on Immune Modulation, Autoimmune Research, published in Cell J (2023) — summary generated from the PubMed abstract.
- 2023
Cell J13 citations - Level DAnimal StudyEurope PMC
Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic "Neo-Islets", 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biothe
Animal Study with a reported sample of 6 on Type 1 Diabetes, Chronic Inflammation, Autoimmune Research, published in PLoS One (2023) — summary generated from the PubMed abstract.
- 2023
- n = 6
PLoS One3 citations - Level BRandomized Controlled TrialPubMed
Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses.
Randomized Controlled Trial on Tendon Injury, published in Cells (2023) — summary generated from the PubMed abstract.
- 2023
Cells - Level DLaboratory StudyEurope PMC
Human meniscus allograft augmentation by allogeneic mesenchymal stromal/stem cell injections
Laboratory Study on Meniscus Injury, published in J Orthop Res (2022) — summary generated from the PubMed abstract.
- 2022
J Orthop Res9 citations - Level DNarrative ReviewEurope PMC
The promising role of autologous and allogeneic mesenchymal stromal cells in managing knee osteoarthritis. What is beyond Mesenchymal stromal cells?
Narrative Review on Knee Osteoarthritis, Osteoarthritis, published in J Clin Orthop Trauma (2022) — summary generated from the PubMed abstract.
- 2022
J Clin Orthop Trauma7 citations - Level BRandomized Controlled TrialEurope PMC
Intra-Articular Injections of Allogeneic Mesenchymal Stromal Cells vs. High Molecular Weight Hyaluronic Acid in Dogs With Osteoarthritis: Exploratory Data From a Double-Blind, Randomized, Prospective Clinical Trial
Randomized Controlled Trial on Osteoarthritis, published in Front Vet Sci (2022) — summary generated from the PubMed abstract.
- 2022
Front Vet Sci6 citations - Level BRandomized Controlled TrialPubMed
Clinical and laboratory findings following transplantation of allogeneic adipose-derived mesenchymal stromal cells in knee osteoarthritis, a brief report.
Randomized Controlled Trial on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Immune Modulation, published in Connect Tissue Res (2022) — summary generated from the PubMed abstract.
- 2022
Connect Tissue Res16 citations - Level DNarrative ReviewPubMed
A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis.
Narrative Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Stem Cell Res Ther (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cell Res Ther17 citations - Level BClinical TrialEurope PMC
Allogeneic mesenchymal stromal cells for cartilage regeneration: A review of in vitro evaluation, clinical experience, and translational opportunities
Clinical Trial on Cartilage Damage, published in Stem Cells Transl Med (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cells Transl Med26 citations - Level BRandomized Controlled TrialPubMed
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: s
Randomized Controlled Trial with a reported sample of 30 on Type 2 Diabetes, Peripheral Artery Disease, published in Trials (2021) — summary generated from the PubMed abstract.
- 2021
- n = 30
Trials10 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406